Skin Disorders News

LOUISVILLE, Ky. — All patients treated with one infusion of NTLA-2002 gene therapy have remained hereditary angioedema attack-free, according to data presented at American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

LOUISVILLE, Ky. — Patients with chronic spontaneous urticaria experienced improvements with dupilumab, according to a study presented at the American College of Asthma & Immunology Annual Scientific Meeting.

LOUISVILLE, Ky. — Allergen-specific immunotherapy showed efficacy among patients with atopic and contact dermatitis overlap syndrome, according to results of a pilot study.

LOUISVILLE, Ky. — Researchers showed with moderate certainty that topical calcineurin inhibitors did not increase cancer risk when used as a treatment for atopic dermatitis among infants, children and adults, according to study results.

LOUISVILLE, Ky. — In this Healio exclusive, Brian T. Kelly, MD, MA, FACAAI, program chair of the American College of Allergy, Asthma & Immunology Annual Scientific Meeting, highlights key sessions and themes of this year’s meeting.

LOUISVILLE, Ky. — Eczema and food allergy are linked, but children with severe, early-onset eczema before age 3 months are at highest risk, a speaker said at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Upadacitinib was well tolerated with no new important safety risks among patients with moderate to severe atopic dermatitis treated for approximately 1 year, according to a study published in The Journal of Allergy & Clinical Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in October.

A 200 mg dose of abrocitinib met stringent efficacy endpoints among substantial portions of patients with moderate to severe atopic dermatitis, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Clinics visits for itch and atopic dermatitis increased among adults aged 65 years and older during the California Camp Fire in 2018 compared with weeks without wildfire, according to a research letter published in JAMA Network Open.